Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Retained Earnings (2016 - 2025)

Gyre Therapeutics (GYRE) has disclosed Retained Earnings for 16 consecutive years, with -$1.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Retained Earnings fell 79.7% to -$1.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$1.7 million, a 79.7% decrease, with the full-year FY2024 number at -$2.6 million, up 96.96% from a year prior.
  • Retained Earnings was -$1.7 million for Q3 2025 at Gyre Therapeutics, up from -$2.3 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $5000.0 in Q1 2021 to a low of -$417.2 million in Q1 2022.
  • A 5-year average of -$185.4 million and a median of -$78.0 million in 2024 define the central range for Retained Earnings.
  • Peak YoY movement for Retained Earnings: surged 100.0% in 2021, then crashed 37048300.0% in 2022.
  • Gyre Therapeutics' Retained Earnings stood at -$402.7 million in 2021, then fell by 2.05% to -$410.9 million in 2022, then skyrocketed by 79.18% to -$85.5 million in 2023, then soared by 96.96% to -$2.6 million in 2024, then soared by 34.54% to -$1.7 million in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Retained Earnings are -$1.7 million (Q3 2025), -$2.3 million (Q2 2025), and -$70.8 million (Q1 2025).